Evidence map›Paper›PMID 23571781›Full record

ArticleMedical molecular morphology2013

Collision tumors of hepatocellular carcinoma and malignant peritoneal mesothelioma.

Junko Uemoto, Nobuo Hoshi, Kaoru Hirabayashi, Sayuri Hoshi, Kei Onodera, Tomohiro Nishi, Moriaki Tomikawa, Seiji Igarashi

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Junko UemotoDepartment of Palliative Medicine, Okayama Saiseikai General Hospital, 1-17-18 Ifuku-chou, Kita-ku, Okayama, Okayama, 700-8511, Japan, uemotoj@gmail.com.
Nobuo Hoshi
Kaoru Hirabayashi
Sayuri Hoshi
Kei Onodera
Tomohiro Nishi
Moriaki Tomikawa
Seiji Igarashi
Tochigi Cancer Center · JPOkayama Saiseikai General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of synchronous hepatocellular carcinoma (HCC) and malignant peritoneal mesothelioma (MM-per). A 56-year-old man with no past history of asbestos exposure, chronic viral hepatitis, or alcoholic liver injury was admitted to our hospital with left flank pain and abdominal tumor. Partial hepatectomy, splenectomy, partial diaphragm resection, and partial gastrectomy were performed. The tumor in the lateral segment of the liver was gray to white, massive in appearance, and contained focal bile-producing nodules and extensive fibrous firm lesion. It had directly invaded the spleen and diaphragm. Liver cirrhosis was not found. The peritoneum contained multiple small nodules especially around the diaphragm, which mimicked carcinoma dissemination. After histological examination, the liver tumor was diagnosed as HCC. It had trabecular and scirrhous patterns and positive immunoreactivities for Hep-Par-1 and α-fetoprotein. The peritoneal nodules were diagnosed as MM-per, epithelioid type, with positive immunoreactivities for calretinin and cytokeratin 5/6. The two tumors collided around the diaphragm. Cases of MM synchronous with other primary malignant tumors have been reported, but most had a history of asbestos exposure unlike the present case. The carcinogenic background was unclear for two tumors in this case. This is an extremely rare and valuable case.

Indexed as

Carcinoma, HepatocellularCombined Modality TherapyFatal OutcomeHumansLiverLiver NeoplasmsLung NeoplasmsMaleMesotheliomaMesothelioma, MalignantMiddle AgedNeoplasms, Multiple PrimaryPeritoneal NeoplasmsRadiography

Identifiers

PMID23571781
OpenAlexW1991735000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.